AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

Piramal Pharma invests $90m to expand its two US facilities, enhancing manufacturing capabilities for sterile injectables and ...

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...

The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...

Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.

As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...

WHO director Dr Tedros Adhanom Ghebreyesus says all hypotheses are on the table, as the organisation works to reinforce ...